A randomized controlled trial of SOF/VEL/VOX with or without ribavirin for retreatment of chronic hepatitis C.
Journal of hepatology（2023）
摘要
NCT04695769.
更多查看译文
关键词
DAA treatment-failure,Ribavirin,SOF/VEL/VOX,direct-acting antivirals,hepatitis C virus
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要